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Roles of the Left Atrial Roof and
Pulmonary Veins in the Anatomic Substrate
for Persistent Atrial Fibrillation and Ablation
in a Canine Model
Kunihiro Nishida, MD, PHD,†§ Jean-François Sarrazin, MD,‡ Akira Fujiki, MD,§ Hakan Oral, MD,‡
Hiroshi Inoue, MD,§ Fred Morady, MD,‡ Stanley Nattel, MD*†
Montreal, Quebec, Canada; Ann Arbor, Michigan; and Toyama, Japan
Objectives The aim of this study was to establish the electrophysiological consequences of pulmonary vein encircling abla-
tion (PVEA) and linear left atrial roof ablation (LARA) for the atrial fibrillation (AF) substrate in an experimental
model.
Background Sequential application of ablation lesions is often used in the management of AF, almost always incorporating
PVEA and LARA.
Methods Atrial tachypacing (400 beats/min, 5 weeks) was used to create an AF substrate in 13 dogs. PVEA and LARA
were applied in randomized order. Regional atrial refractoriness, AF vulnerability, AF duration, and activation
during AF were assessed before and after applying ablation lesion sets.
Results PVEA failed to terminate AF or affect AF duration (742  242 s before vs. 627  227 s after PVEA) but de-
creased AF vulnerability to single extrastimuli from 91  4% to 59  5% (p  0.001) by increasing effective
refractory periods at sites with suppressed AF induction (from 78  4 ms to 102  8 ms, p  0.01). LARA ter-
minated AF in 67% of dogs (p  0.05 vs. PVEA) and reduced AF duration (from 934  232 s to 322  183 s,
p  0.01) without affecting AF vulnerability. Baseline AF mapping showed left atrial (LA)-dominant complex re-
activations (LA 9.4  0.9 vs. right atrial 1.1  0.3 reactivations/500-ms window, p  0.001), with the LA roof
frequently involved in re-entry circuits (44  9% of LA reactivations). LARA terminated AF by interrupting LA roof
reactivation circuits. In 5 of 13 cases, macro–re-entrant tachycardias (usually perimitral) occurred after LARA
eliminated persistent AF.
Conclusions Both PVEA and LARA had beneficial but limited actions in this canine model. LARA suppressed AF perpetuation
by interrupting LA roof reactivation, without affecting AF vulnerability. PVEA suppressed AF initiation by prolong-
ing regional effective refractory period but failed to affect the AF-perpetuating substrate. These findings indicate
the need to systematically study individual stepwise components to refine AF ablation procedures. (J Am Coll
Cardiol 2010;56:1728–36) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.05.051a
e
a
(
r
o
(
v
a
dtrial fibrillation (AF) is a very common, therapeutically
hallenging arrhythmia (1,2). Although left atrial (LA)
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010, accepted May 18, 2010.blation procedures targeting the pulmonary veins (PVs) are
ffective for treating paroxysmal AF (3,4), PV isolation
lone has limited efficacy in persistent or permanent AF
4–6). Additional ablation lines, often involving left atrial
oof ablation (LARA) as a second step, improve procedural
utcomes (7,8) and are effective in managing persistent AF
9). Studies of the “stepwise ablation approach” have pro-
See page 1737
ided insights into some aspects of the contribution of
blating various regions in human AF (10,11). However,
etailed repeated analyses of changes in electrophysiological
roperties and atrial activation after each step are difficult to
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November 16, 2010:1728–36 Effects of LA Roof Versus PV Ablation in AFbtain during clinical procedures. There has been no sys-
ematic analysis of the effects of components of stepwise
rocedures for AF ablation in animal models. We hypoth-
sized that such components could have discrete effects on
he AF substrate, and studied the consequences of PV
ncircling ablation (PVEA) and LARA in dogs with a
ersistent AF substrate. We chose this model because of its
otential relevance to the persistent AF substrate in hu-
ans, recognizing that some forms of clinical AF (e.g.,
aroxysmal AF) likely have very different mechanisms.
ethods
xperimental groups. Animal-handling procedures were
pproved by the local animal research ethics committee.
VEA and LARA were performed in randomized order in
3 mongrel dogs weighing 25.6 to 34.0 kg. In 7 dogs (group
), PVEA was applied first, and in 6 dogs (group 2), LARA
as applied first. Dogs were subjected to atrial tachypacing,
s previously described (12,13). Dogs were anesthetized
ith intravenous ketamine (5.3 mg/kg), intravenous diaze-
am (0.25 mg/kg), and halothane (1.5%). A bipolar pacing
ead was inserted into the right atrial (RA) appendage and
onnected to a pacemaker (SIP 501, Star Medical, Tokyo,
apan) in the neck. After 24-h post-operative recovery,
-week atrial pacing at 400 beats/min was initiated. Oral
igoxin (0.25 mg/day) was administered to control ventric-
lar response. Open-chest electrophysiological studies were
erformed after 5 weeks.
tudy protocols. At open-chest study (median sternot-
my), atrial pacemakers were deactivated. Dogs were anes-
hetized with subcutaneous morphine (2 mg/kg) and alpha-
hloralose (120 mg/kg load, 29.25 mg/kg/h) and ventilated
echanically. Body temperature was maintained at 37°C.
ipolar electrodes were hooked into the RA and LA
ppendages. Silicon sheets containing 240 bipolar electrodes
ere sutured onto atrial surfaces for mapping (14). Six
roup 1 and 5 group 2 dogs (85% of all study animals) were
n persistent AF when atrial pacemakers were deactivated;
F was cardioverted before baseline electrophysiological
tudies. PVEA or LARA was then performed, and electro-
hysiological studies were repeated. Atrial effective refrac-
ory period (ERP) was measured with 10 basic stimuli (S1s)
ollowed by premature extrastimuli (S2s) (all stimuli 2 
hreshold current 2-ms pulses) in 5-ms increments. At least
min of pacing was applied at each basic cycle length before
RP determination to ensure steady-state conditions, a 1-s
ause was used to observe the response to S2s, and the ERP
as determined by incrementing from noncapturing S1-S2s
o that captured beats produced minimal interference with
he basic frequency. The longest S1-S2 failing to capture
efined the ERP. ERPs were measured at basic cycle
engths of 150, 200, 250, 300, and 360 ms in the LA and
hen RA appendages and at a basic cycle length of 300 ms
t 6 additional sites in the following order: RA posterior
all, RA inferior wall, RA Bachmann’s bundle, LA Bach- Aann’s bundle, LA inferior wall,
nd LA posterior wall. AF vul-
erability was the percent of atrial
ites at which AF 1 s was in-
uced by S2s. AF was defined as
n irregular atrial arrhythmia at
400 beats/min. To estimate
ean AF duration in each dog
12–14), AF was induced with 1-
o 10-s burst pacing (10 Hz, 4 
hreshold current). Persistent AF
30 min) was terminated by
irect current cardioversion. If
ersistent AF was induced twice,
blation procedures were per-
ormed 5 min into a third persis-
ent AF episode to determine the
bility to terminate AF. Activa-
ion was assessed as previously
escribed (14) over a 500-ms window at baseline and after
ach ablation step for each AF episode.
The frequency-content of fibrillatory activity was ana-
yzed by fast Fourier transformation of bipolar potentials
ver 40-s periods (15). The dominant frequency (DF) at
ach electrode was based on the peak in the power spectrum
etween 5 and 20 Hz.
blation. Ablations were performed during persistent AF
hen it was reproducibly inducible (9 dogs) or otherwise
uring sinus rhythm. PVEA was performed on the antrum
f both right and left PVs about 0.5 to 1.0 cm from the ostia
y delivering 32.5-W applications via a bipolar epicardial
adiofrequency clamp. Each PV was mapped epicardially on
segments (anterior and posterior cranial, anterior and
osterior caudal, ventral, and dorsal) with a bipolar electrode
robe for the presence of PV potentials. Completed PVEA
as confirmed by loss of PV responses to LA stimulation
nd of LA response to PV stimulation at all PV sites distal
o the ablation line.
For LARA, a bipolar epicardial radiofrequency ablation
en device was inserted posterior to the left atrium above
he left superior PV and advanced to above the right
uperior PV. Radiofrequency energy (35 W through 100-
esistance) was delivered point by point for 30 s at each site
rom the right to left superior PVs. A completed LARA line
as confirmed by discrete double potentials along the
blation line.
ata analysis. Continuous variables are expressed as
ean  SEM. Fisher exact tests were used to compare
requencies. Paired t tests were used to compare paired
ithin-group observations, 2-way repeated-measures anal-
sis of variance was used to analyze the main effects of
blation on ERPs across basic cycle lengths and atrial
egions, and analysis of variance with Bonferroni-corrected
tests was used to evaluate DF changes with ablation and
VEA effects on ERP according to vulnerability responses.
Abbreviations
and Acronyms
AF  atrial fibrillation
DF  dominant frequency
of fast Fourier–transformed
signals
ERP  effective refractory
period
LA  left atrial
LARA  left atrial roof
ablation
PV  pulmonary vein
PVEA  pulmonary vein
encircling ablation
RA  right atrial
S1  basic stimulus
S2  premature stimulusll data were normally distributed, except AF duration,
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Effects of LA Roof Versus PV Ablation in AF November 16, 2010:1728–36hich was normal after log transformation. Two-tailed
values 0.05 indicated statistical significance.
esults
igure 1A illustrates the lesions applied to produce PVEA
nd LARA. PV potentials were abolished by PVEA
Fig. 1B). LARA produced bidirectional block across the
blation line, with double potentials on either site of the
blation line (Fig. 1C).
blation-induced AF termination. First-step PVEA
ailed to terminate persistent AF in 5 dogs in group 1.
ubsequent LARA terminated AF in 3 of 5 dogs. In group
, first-step LARA terminated persistent AF in 3 of 4 dogs.
ubsequent PVEA in the dog in which LARA failed did
ot terminate AF. Thus, overall PVEA terminated persis-
ent AF in 0 of 6 dogs, whereas LARA terminated AF in 6
f 9 dogs (67%, p  0.05).
VEA and LARA effects on atrial electrophysiology.
either PVEA nor LARA significantly affected sinus cycle
ength (415  15 ms before vs. 406  16 ms after PVEA
nd 416 16 ms before vs. 405 17 ms after LARA). The
ffects of PVEA and LARA were similar whether they were
pplied as the first or second step (Online Fig. 1 to 4).
herefore, electrophysiological data are grouped per proce-
ure. PVEA did not affect AF duration (742 242 s before
s. 627  227 s after PVEA) (Fig. 2A) but decreased AF
ulnerability (Fig. 2B) from 91  4% to 59  5% (p 
‡
*
Before PVEA
After PVEA
II
RA
PV
II
RA
PV
A
A
A B
LAA pacing 
CL=240 ms
LARA line
PVEA lines*
‡ Recording sites
Figure 1 Lesion Sites and Effects on Local Activity
(A) Schematics of pulmonary vein encircling ablation (PVEA) (top) and left atrial (L
electrograms from the right atrial (RA) appendage and left superior pulmonary vein
cardial electrograms above and below LARA line during left atrial appendage (LAA
P-wave; S  stimulus artifact; V  far-field ventricular potential..001). PVEA reduced mean DF (Fig. 2C) by 10  2% in She left atrium and by 7  2% in the right atrium. ERP was
ot significantly changed in the LA appendage (Fig. 2D)
ut was increased in the RA appendage (Fig. 2E) and across
trial regions (Fig. 2F).
LARA reduced AF duration (from 934 232 s to 322
83 s, p  0.01) (Fig. 3A) without affecting AF vulnera-
ility (Fig. 3B). LARA-induced DF decreases (Fig. 3C)
veraged 16  5% in the left atrium and 17  3% in the
ight atrium, exceeding those produced by PVEA (10  2%
n the left atrium, 7  2% in the right atrium, p  0.16 and
 0.05 vs. LARA, respectively). LARA did not affect
trial ERP (Figs. 3D to 3F).
Persistent AF was inducible by burst pacing in 11 of 13
ogs at baseline. In group 1, first-step PVEA abolished
ersistent AF induction in 1 of 6 dogs, and second-step
ARA prevented persistent AF induction in 4 of 5 remain-
ng dogs. In group 2, first-step LARA prevented persistent
F induction in 3 of 5 dogs, and second-step PVEA
revented persistent AF induction in 1 of 2 remaining dogs.
hus, overall LARA prevented AF induction by burst
acing in 7 of 10 dogs (70%) compared with 2 of 7 dogs
28%) with PVEA.
VEA effects on AF vulnerability. ERP values at sites
ith versus without successful AF induction by S2s are
hown in Online Figure 5. At baseline, S2 sites with
uccessful AF induction had shorter ERPs than nonin-
ucible sites (79  2 ms vs. 106  6 ms, p  0.05).
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November 16, 2010:1728–36 Effects of LA Roof Versus PV Ablation in AFith significant ERP prolongation (from 78 4 ms to 102
ms, p 0.01) at sites with suppressed AF induction; ERP
as unchanged at sites without prevention of AF induction,
uggesting that PVEA suppressed AF initiation by prolong-
ng local ERPs.
echanisms of effects on AF perpetuation. Figure 4
hows selected electrograms (Fig. 4A) and activation se-
uences at all electrode sites (Fig. 4B) during persistent AF
t baseline in a dog from group 2. Corresponding activation
aps are shown in Online Figure 6. More rapid and
omplex activation occurred in the left atrium than the right
trium, with LA-dominant complex reactivations frequently
ncluding the LA roof. In the first window mapped (Online
ig. 6A), activity began in the inferior-posterior left atrium.
igure-of-eight activation resulted in late excitation of 2
reas adjacent to early-activating zones (designated sites 1
nd 2). Reactivation at sites 1 and 2 initiated LA activity in
he next cycle. At least 1 reactivation zone (a region of
arly-activated tissue, adjacent to late-activated tissue,
hich was reactivated early in the next window, designated
y circled numbers in Online Fig. 6) was observed in the left
trium for each window mapped. There were 10.5  1.0
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Figure 2 Effects of PVEA on Electrophysiological Variables and
(A) Mean  SEM duration of induced atrial fibrillation (AF). (B) Mean  SEM AF v
dominant frequency (DF) values. (D, E) Mean  SEM effective refractory period (E
respectively. (F) ERPs in atrial regions at 300-ms basic cycle length (BCL). *p  0
ferroni-corrected t test (C), or analysis of variance of ablation main effects (D to F
atrial posterior wall; PVEA  pulmonary vein encircling ablation; RABB  right atrial Baeactivation zones per 500-ms mapping window during maseline AF, with more reactivation zones in the left atrium
han the right atrium (9.4  0.9 vs. 1.1  0.3 reactivation
ones/500-ms window, p  0.001). The LA roof was
ommonly involved (3.6  0.6 reactivation zones/500-ms
indow, 44  9% of LA total).
Figure 5 illustrates AF termination after first-step LARA
n the same dog as shown in Figure 4. The LA activation
equence (Fig. 5A) was now much more regular than before
blation (Fig. 4B), and RA activity was more irregular and
aster than LA activity. After LARA, AF was maintained
y RA re-entry (Figs. 5B to 5D) that was slower than LA
e-entry before ablation (Fig. 4), possibly explaining DF
lowing by LARA. Termination of RA re-entry was fol-
owed by 2 activations of unknown origin (Figs. 5E and 5F)
nd then cessation of activity.
An example of persistent AF induced after first-step PVEA
n a group 1 dog is shown in Figure 6. LA activation was
egular and rapid (cycle length 96 ms), circulating around the
eft PVEA line; the right atrium showed slower, more irregular
ctivation. After first step PVEA, AF was maintained by stable
e-entry around the PVEA line in 3 of 5 group 1 dogs with
ersistent AF after PVEA. In the other 2 dogs, no clear
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Effects of LA Roof Versus PV Ablation in AF November 16, 2010:1728–36Although AF could not be reinitiated in most dogs
fter LARA, regular macro–re-entrant atrial tachycar-
ias, virtually always in the perimitral area, were com-
only inducible (2 of 7 group 1 dogs, 3 of 6 group 2
ogs). An example is shown in Online Figure 7. The
ean cycle length of such tachycardias, clearly distin-
uishable from AF on the basis of cycle length and
egularity, was 145  12 ms.
iscussion
n this study, we assessed the effects of PVEA and LARA
n atrial electrophysiology and AF. LARA suppressed AF
erpetuation by interrupting LA reactivation circuits but did
ot alter AF vulnerability. PVEA suppressed AF initiation
y prolonging local ERP values but failed to affect the AF
erpetuating substrate.
revious clinical studies of linear AF ablation. The
ddition of LA ablation lines (e.g., targeting the LA roof
nd mitral isthmus) to PV isolation procedures improves
F suppression (7,8). Six months after ablation, 67% of
atients who underwent PV isolation compared with 88%
f patients who underwent circumferential PV ablation,
ncluding PVEA, LARA, and mitral isthmus ablation,
ere AF free without antiarrhythmic drug therapy (7).
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Figure 3 Effects of LARA on Electrophysiological Variables and
Format and statistics as in Figure 2. LARA  left atrial roof ablation; other abbrevif patients with inducible AF after PV isolation, LARA daused arrhythmia termination in 47% and AF nonin-
ucibility in 59% (8).
Although circumferential PV ablation, generally includ-
ng additional LA linear ablations, is effective for persistent
F (9), no clinical data are available regarding the effect of
ARA alone without PV isolation, and the individual
ontribution is not well understood. LA linear ablation
ailing to isolate PVs was as effective as circumferential PV
blation in 80 patients with persistent AF (16).
nimal studies of linear AF ablation. Several studies
ave demonstrated that multiple linear ablation lesions
up to 8 ablation lines per dog) can suppress AF in canine
odels (17–20). In a vagal stimulation AF model, biatrial
inear ablation rendered AF noninducible in all (17,18).
n a long-term atrial tachypacing model, right-sided
inear ablation suppressed AF in 5 of 9 dogs, and
dditional LA ablation lesions abolished AF in the other
(19). Linear biatrial ablation lesions (8 per dog) in
n atrial tachypacing and mitral regurgitation canine per-
istent AF model eliminated sustained AF in 8 of 9
ogs (20).
There are few published data on PV ablation in animal
F models. Extensive radiofrequency ablation around PVs,
he superior vena cava, and the vein of Marshall converted
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Figure 4 Activation During Persistent AF in a Group 2 Dog at Baseline
(A) Electrograms recorded at sites indicated on the schematic at the top. (B) Activation times at all 240 recording sites during a 500-ms mapping window (for corre-
sponding activation maps, see Online Fig. 6). AF  atrial fibrillation; LAFW  left atrial free wall; LAR  left atrial roof; RAFW  right atrial free wall; other abbreviations
as in Figure 2.0 ms
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Figure 5 AF Termination During First-Step LARA in a Group 2 Dog
Results in this figure are for the same dog as in Figure 4 and Online Figure 6, with the same format.
The LAR electrode array was removed for the ablation. Abbreviations as in Figures 2, 3, and 4.
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Effects of LA Roof Versus PV Ablation in AF November 16, 2010:1728–3621). Resection of all PVs failed to suppress atrial tachyar-
hythmias in coronary-perfused LA PV preparations from
ogs with AF promotion due to rapid atrial pacing (22). In
anine cholinergic AF models, sustained AF was inducible
n all dogs after isolation of all PVs both in vivo and in vitro
23). No experimental studies have compared the effects of
VEA and LARA, alone or in combination, on a persistent
F substrate and associated electrophysiological determinants.
echanisms of LARA effects on AF persistence. In
atients with paroxysmal AF, propagation occurs around
rcs of functional conduction block, descending down the
osterior LA wall from the roof region, in association with
brupt changes in subendocardial muscle fiber orientation
24,25). During AF initiation, wave fronts interact with
lock lines, producing macro–re-entry or daughter wave
ronts (24). Electroanatomic mapping suggested that struc-
urally related conduction block is important for LA flutter
r AF after PV isolation (25). These findings agree with our
bservation of frequent involvement of LA roof reactivation
n AF maintenance and of LA re-entry maintaining AF
fter PVEA.
Several studies have indicated an important contribution
f focal drivers in the LA roof and posterior left atrium in
aintaining AF. During clinical AF associated with organic
eart disease, the activation cycle length is shorter in the
osterior LA wall than the RA free wall (26). Complex
ractionated atrial electrograms are frequently found in the
A roof (27,28). During acetylcholine-induced AF in sheep
earts, the posterior left atrium shows spatiotemporally
rganized activity suggesting local driver regions (29). In
heep with heart failure–associated AF, heterogeneous fi-
rosis in the posterior left atrium anchors re-entry and
c
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g h
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Figure 6 Activation During Persistent AF Induced After First-St
Format and abbreviations as in Figures 2, 3, and 4 and Online Figure 6.enerates conduction delays, wave breaks, and signal frac- tionation (30). Because the LA roof is located in the
osterior LA wall, LARA may interfere with driver wave
ctivity emanating from the posterior left atrium.
echanisms of PVEA effects. PVEA suppressed AF
nitiation by prolonging regional ERP. PV ablation affects
he autonomic ganglia near the PV ostia (31,32). Auto-
omic denervation may have contributed to PVEA-induced
egional ERP prolongation and suppression of AF initiation
n the present study. PVEA failed to affect the AF-
erpetuating substrate. The clinical efficacy of PV isolation
lone is limited in persistent or permanent AF, in contrast
o paroxysmal AF (4–6). These results are compatible with
he dominant high-frequency PV drivers seen in patients
ith paroxysmal but not persistent AF (5).
table macro–re-entry after AF ablation. We found peri-
itral macro–re-entry causing regular atrial tachycardias
fter LARA and stable re-entry around the PVEA line
aintaining AF after PVEA. LA tachycardias from recon-
ected PV foci occur after segmental PV isolation and
ontinuous circular lesions around ipsilateral PVs (33,34).
erimitral macro–re-entry and re-entry around ipsilateral
Vs are common causes of recurrent arrhythmia after
ircumferential PV ablation, commonly (35,36) but not
lways (8,25,37) related to gaps in ablation lines. Macro–
e-entry around the right PVs occurred in 3 and the mitral
alve in 1 of 90 patients after PV isolation (8). After
dditional LARA, perimitral LA flutter was induced in 9 of
5 patients. Chang et al. (25) reported that 24 of 43 patients
ad inducible LA flutter after PV isolation, typically circu-
ating around the mitral annulus and/or PVs. Our observa-
ions of perimitral macro–re-entry after combined PVEA
nd LARA, and peri-PV re-entry after PVEA, are consis-
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November 16, 2010:1728–36 Effects of LA Roof Versus PV Ablation in AFerimitral macro–re-entry was induced even after first-step
ARA without PVEA, suggesting that a large enough
blation lesion in the LA roof may induce perimitral
acro–re-entry without PVEA lines.
otential significance. Stepwise ablations are commonly
erformed for persistent AF. There have been no systematic
tudies of the role of individual components of stepwise
rocedures in randomized order. Our study, the first to
ddress this issue, suggests that components of stepwise
blation procedures have discrete effects on the AF sub-
trate. Further investigation of the specific effects of indi-
idual stepwise components on persistent AF substrates
ould be useful. The information obtained might allow for
he design of more rationally based and potentially individ-
alized procedures, in terms of both the types of lesions
eeded and their order. Such an approach could improve
fficacy by optimization of procedures and might permit
ore limited procedures by eliminating components that
re unnecessary for specific patients.
ossible limitations. In our experiments, septal activation
ata were not obtained. Thus, the entire re-entrant circuit
ould not be mapped during some episodes. Because we
bserved only short-term ablation effects, we may have
issed delayed changes that occur over weeks to months. It
ould be interesting to perform follow-up studies to assess
he stability of the effects of ablation over the longer term in
hronically followed survival animals.
We used a specific animal model of AF that produces a
ubstrate for persistent AF. The mechanisms underlying
aroxysmal AF are likely to be different. In addition, human
F is likely to be much more complex than AF produced in
elatively much more straightforward animal models.
herefore, extrapolation of our results to human AF para-
igms should be very cautious. In addition, different results
ight be obtained in other experimental AF models.
Our ERP measurements were obtained with a 10-
timulus basic drive train. Although this is a standard
pproach in clinical and basic research, it does not produce
bsolute steady-state conditions.
onclusions
e systematically studied the effects of LARA and PVEA
n a canine persistent AF model. Both PVEA and LARA
ad beneficial but limited and specific actions: LARA
uppressed AF perpetuation by interrupting LA reactivation
ircuits, whereas PVEA suppressed AF initiation by pro-
onging regional ERP without affecting the AF-perpet-
ating substrate. These findings indicate the need to sys-
ematically study individual stepwise components to refine
blation procedures for persistent AF.
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